| Top 10 | Portfolio net assets ($M) | 1-year return | 3-year return | 5-year return | Expense ratio* |
|---|---|---|---|---|---|
| Highland Long/Short Healthcare Fund A (HHCAX) | $277.8 | 36.62% | 7.64% | 13.03% | 2.92% |
| Gotham Enhanced Return Fund Institutional (GENIX) | $801.9 | 33.29% | N/A | N/A | 3.62% |
| MainStay U.S. Equity Opportunities Fund I (MYCIX) | $428.5 | 25.78% | 19.34% | 19.20% | 2.36% |
| American Century Core Equity Plus Fund A (ACPQX) | $150.8 | 23.07% | N/A | N/A | 2.12% |
| Gotham Absolute Return Fund Institutional (GARIX) | $1,543.0 | 21.21% | N/A | N/A | 3.24% |
| JPMorgan US Dynamic Plus Fund Select (JILSX) | $270.2 | 20.18% | 16.04% | 16.55% | 1.75% |
| Convergence Core Plus Fund Institutional (MARNX) | $321.8 | 18.74% | 17.01% | N/A | 2.21% |
| Virtus Dynamic AlphaSector Fund A (EMNAX) | $2,690.4 | 17.41% | 11.68% | 6.33% | 3.06% |
| Highland Long/Short Equity Fund Z (HEOZX) | $1,064.4 | 14.60% | 6.90% | 7.12% | 2.37% |
| Robeco Boston Partners Long/Short Research Fund Institutional (BPIRX) | $4,402.7 | 13.89% | 10.87% | N/A | 2.75% |
| Bottom 5 | |||||
| Direxion Indexed Managed Futures Strategy A (DXMAX) | $102.6 | -12.93% | N/A | 0.00% | 1.45% |
| Forward Credit Analysis Long/Short Fund Inv (FLSRX) | $111.1 | -10.15% | 2.50% | 5.98% | 1.84% |
| Columbia Absolute Return Enhanced Multi-Strategy Z (CEMZX) | $143.4 | -6.22% | 0.08% | N/A | 1.57% |
| Altegris Macro Strategy Fund I (MCRIX) | $127.5 | -5.96% | -7.01% | N/A | 2.09% |
| Pacific Life Currency Strategies P | $135.2 | -5.71% | N/A | N/A | 0.88% |
| Total/average | $318,388.9 | 3.99% | 3.29% | 5.72% | 2.09% |
| LIBOR USD 3 Months | 0.25% | 0.33% | 0.34% |
Assets as of April 30, returns as of June 3. Distinct classes and funds with $100 million portfolio minimum only. Excludes leveraged and inverse funds. Funds closed to new investors have been omitted for the top-10 grouping. Rankings are based on unrounded figures. Three and five-year returns are annualized. In case of multiple share classes, the oldest share class is listed. N/A = not available (fund has been in operation for less than the year indicated). *Net prospectus Source: Lipper
From outstanding individuals to innovative organizations, find out who made the final shortlist for top honors at the IN awards, now in its second year.
Cresset's Susie Cranston is expecting an economic recession, but says her $65 billion RIA sees "great opportunity" to keep investing in a down market.
“There’s a big pull to alternative investments right now because of volatility of the stock market,” Kevin Gannon, CEO of Robert A. Stanger & Co., said.
Sellers shift focus: It's not about succession anymore.
Platform being adopted by independent-minded advisors who see insurance as a core pillar of their business.
RIAs face rising regulatory pressure in 2025. Forward-looking firms are responding with embedded technology, not more paperwork.
As inheritances are set to reshape client portfolios and next-gen heirs demand digital-first experiences, firms are retooling their wealth tech stacks and succession models in real time.
